Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07002437 · ClinicalTrials.gov registry record · NA

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

A NA study of Spinal Cord Injuries (SCI), sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT07002437 is a NA study of Spinal Cord Injuries (SCI) that is actively recruiting participants, run by University of Florida. The registered enrollment target is 18 participants, below the 66-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07002437, a NA study of Spinal Cord Injuries (SCI), is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Spinal cord injury (SCI) disrupts neural pathways to respiratory motor neurons, diminishing breathing capacity and airway defense (e.g., cough). Indeed, respiratory impairment is a leading cause of infection, re-hospitalization and death after SCI. There is a critical need for new strategies to restore breathing ability and airway defense in people with SCI. Acute intermittent hypoxia (AIH) - repetitive exposure to brief episodes of low inspired oxygen - is a promising strategy to restore breathing capacity by promoting spinal neuroplasticity. Exciting outcomes in \>12 SCI trials completed to date demonstrate that AIH improves human respiratory and limb function. Unfortunately, \~40% of individuals exhibit minimal response to AIH, making it essential to 1) optimize AIH protocols to maximize functional benefits; and 2) identify genetic biomarkers distinguishing those most/least likely to benefit from AIH-based treatments. The purpose of the pilot study, to be conducted in a small sample of participants with sub-acute SCI (2 weeks to 6 months post injury), is to preliminarily compare the effects of two intermittent hypoxia protocols. Since AIH-induced plasticity may be induced via serotonin or adenosine-driven mechanisms and these pathways compete and inhibit each other, each protocol favors a distinct mechanistic pathway. Our long-term objective is to test the hypothesis that a longer duration (i.e., augmented) hypoxia protocol, favoring adenosine mechanisms, enhances respiratory motor plasticity more than an AIH protocol targeting serotonin mechanisms (low O2 + CO2) in people with sub-acute SCI. Since an individual's genetics can influence the response to rehabilitation, we are also investigating how certain genes are related to breathing changes after these treatments. Data acquired through this pilot study will be used to inform a larger, more definitive clinical trial and will contribute to estimations of the magnitude and direction of effects.

Conditions Studied

Interventions

  • OTHER Augmented Acute Intermittent Hypoxia (aAIH)
  • OTHER Acute Intermittent Hypercapnic-Hypoxia (AIHH)
  • OTHER Sham AIH

Study Locations (1)

Florida

  • Brooks Rehabilitation - Jacksonville

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2025-11-20
Est. Completion 2027-07
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT07002437

The ClinicalTrials.gov registry entry for NCT07002437 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 66-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (73% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries (SCI) appearing as the primary indexed condition, and to 3 interventions - of which Augmented Acute Intermittent Hypoxia (aAIH) is the first listed.

NCT07002437 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07002437 about?

NCT07002437 is a clinical study titled "Hypoxia Pathways for Early Recovery After Spinal Cord Injury". Spinal cord injury (SCI) disrupts neural pathways to respiratory motor neurons, diminishing breathing capacity and airway defense (e.g., cough). Indeed, respiratory impairment is a leading cause of infection, re-hospitalization and death after SCI. There is a critical need for new strategies to rest...

What is the current status of trial NCT07002437?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-11-20. Estimated completion is 2027-07.

What conditions does trial NCT07002437 study?

This clinical trial studies the following conditions: Spinal Cord Injuries (SCI).

What interventions are being tested in trial NCT07002437?

The interventions under investigation include: Augmented Acute Intermittent Hypoxia (aAIH) (OTHER), Acute Intermittent Hypercapnic-Hypoxia (AIHH) (OTHER), Sham AIH (OTHER).

Who is sponsoring clinical trial NCT07002437?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07002437 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries (SCI)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.